The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Mon., Oct. 14, 9:37 AM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #71. TearLab Corporation AOA's OcuHub Technology Platform

Acquirer: TearLab Corporation (TEAR)
Acquiree: AOA's OcuHub Technology Platform
Details: TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") today announced the closing of the acquisition of the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association ("AOA").

TearLab is an in-vitro diagnostic company. Co. has commercialized a tear testing platform, the TearLab® Osmolarity System that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Co.'s product measures tear film osmolarity for the diagnosis of dry eye disease. The TearLab® Osmolarity System has three components: the TearLab disposable, which is a single-use microfluidic microchip; the TearLab Pen, which is a hand-held device that interfaces with the TearLab disposable; and the TearLab Reader, which is a desktop unit that allows for the docking of the TearLab Pen and provides a quantitative reading for the operator.

Open the TEAR Page at The Online Investor »

Company Name: 
TearLab Corp
Website: 
www.tearlab.com
Sector: 
Medical Instruments & Supplies
 

Open the TEAR Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 71 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.